FAQ
Log In
Saturday 21st January 2017
News
 › 
 › 

US rescind approval for Avastin

21st November 2011

US drug regulators say Avastin is not effective enough to justify risks of taking it.


Click on available sources in right hand menu to see the original article.

Share this page

Comments

chelsey wayne

Wednesday 23rd November 2011 @ 8:31

Avastin is a cancer drug manufactured by Genentech, a part of Roche Pharmaceuticals. The Food and Drug Administration approval for Avastin was conditional. The Food and Drug Administration allowed it to be used only pending certain studies. Now that those studies have been finished, the approval has been taken away. Here is the proof: Approval pulled for Avastin breast cancer drug


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: US rescind approval for Avastin
Author: Martine Hamilton
Article Id: 20380
Date Added: 21st Nov 2011

Sources

BBC News

Recent Related Articles

Survey used to identify 'fragile' services

Google technology used to treat patients

E-cigarettes could be used to help combat obesity

Actions

Add to scrapbook
Show Comments
Add comment
Find all related articles

Tags

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2017